Cd8 The dominant search intent appears to be understanding the role of peptides in T-cell activation and recognition, particularly in the context of immunology and research. This involves how T-cell receptors (TCRs) interact with peptides presented by MHC molecules.
Tier 1:
* search_keyword: t-cell peptide
* High-relevance phrases: T-cell receptors (TCRs) recognize short peptides, peptides for T-cell stimulation, TCR-mediated recognition of a peptide antigen bound to an MHC-derived molecule, peptides bound to HLA molecules, peptide fragments, antigen-specific T cells.
* Core entities: T cells, peptides, T-cell receptors (TCRs), MHC molecules (including HLA).The T cell encounters a dendritic cell (DC) bearing its cognate peptidein an MHC molecule, and binds the peptide-MHC though CD3 and CD4 or 8. Subsequently ...
Tier 2:
* Related searches: Tcrt, Cd8, Cd3 tcr, Gamma deltat cell
* Search intent phrases: MHC-associated thymic peptides, located on the surface of T cells, available in a wide range of sizes and formats, have typically expanded enough by day 9 or 10, how to prepare peptide pool stocks and PBMC suspensions, five peptides targeting the BTLA-HVEM complex, short protein fragments, super agonist peptide MTSAIGILPV can prime a greater quantity of T-cells, a small peptide sequence, PepTivator® Peptide Pools, T-cell receptors (αβ, TCR) expressed on T cells, stimulating T cells, peptides must be bound to MHC molecules, Empty MHC reagents improve T cell detection, T cells can recognize peptide fragments, The T cell encounters a dendritic cell (DC) bearing its cognate peptide, T cells bearing αβ T cell receptors (TCRs), Individual T cells are usually very specific for particular foreign peptides, Neoantigens are peptides.
* SERP signals: T-cell activating peptide libraries, peptide pools for T cell stimulation, peptide therapy, peptide processing, Neoantigens作者：TMQ Pham·2024·被引用次数：4—Neoantigens are peptidesthat result from somatic mutations and can be displayed by class I human leukocyte antigen (HLA-I) molecules on the ....
Tier 3:
* Bcell, Memory bcell, Cart (These are related to immunology but not directly to the peptide-T-cell interaction as the primary focus)As described in the previous section,T cells can recognize peptide fragmentsthat have been processed and presented by APC, i.e., dendritic cells (DC), ....
---
T-cell peptides are fundamental to the adaptive immune system, acting as the critical molecular signals that T cells recognize to initiate immune responses. These short protein fragments, often referred to as epitopes, are presented by Major Histocompatibility Complex (MHC) molecules on the surface of other cells. The interaction between a T-cell receptor (TCR) and a peptide-MHC complex is a cornerstone of cellular immunity, enabling T cells to distinguish between self and non-self, and to target pathogens or abnormal cells作者：TH Watts·1985·被引用次数：97—The activation of helperT cellsby antigen requires that the antigen be presented by an accessory cell that also expresses self-molecules encoded by the I .... Understanding t-cell peptide interactions is crucial for research in immunology, vaccine development, and the treatment of various diseases.The T Cell Receptor β Chain Repertoire of Tumor ...
T cells, a vital component of the immune system, possess T-cell receptors (TCRs) on their surface. These TCRs are highly specific and are designed to bind to particular peptide antigens presented by MHC molecules. This recognition process is not direct; peptides must first be processed from larger proteins within a cell and then loaded onto MHC molecules.
* MHC Class I: Typically presents peptides derived from intracellular proteins (like viral antigens or self-proteins) to cytotoxic T cells (CD8+ T cells).The T cell epitope isa small peptide sequence, presented by MHC receptors on antigen presenting cells and other nucleated cells, that stimulates immune system ... This interaction often leads to the destruction of the presenting cell.
* MHC Class II: Presents peptides derived from extracellular proteins (like bacterial antigens) to helper T cells (CD4+ T cells). This interaction helps orchestrate broader immune responses, such as B cell activation and antibody production.
The T-cell receptor (TCR) is the primary molecule responsible for "reading" these peptide-MHC complexes. The specific amino acid sequence of the peptide, along with the structure of the MHC molecule presenting it, dictates the TCR's binding affinity and the subsequent T-cell responseT-cell activation. This specificity ensures that the immune system can mount targeted attacks against a vast array of threats.
Peptides are indispensable tools in immunological research and clinical applications, particularly for stimulating T-cell responses.How the T Cell Repertoire Becomes Peptide and MHC ... Researchers frequently use synthetic peptides or peptide pools to activate antigen-specific T cells *ex vivo*. This allows for the study of cellular immunity, the identification of epitopes, and the assessment of immune responses in various conditions, such as infections or cancer.
* T-Cell Activating Peptide Libraries: These libraries offer a wide range of peptides, typically 8 to 30 amino acids long, designed to elicit a T-cell response. They are crucial for epitope mapping and understanding T-cell repertoire作者：SK Saini·2019·被引用次数：119—Empty MHC reagents improve T cell detection. Recombinant MHC molecules displaying single peptides in their peptide-binding cleft are valuable ....
* Peptide Pools: For broad stimulation, peptide pools are often employed. These are collections of overlapping peptides that cover a specific protein or antigen. PepTivator® Peptide Pools, for instance, are optimized for effective stimulation of antigen-specific T cells, aiding in the analysis of immune responses.
* Neoantigens: In the context of cancer, neoantigens are peptides arising from somatic mutations within tumor cellsT-cell activation. These peptides can be presented by MHC molecules and recognized by T cells, making them critical targets for cancer immunotherapy. Identifying and stimulating T cells against these neoantigens is a rapidly advancing area of research.Peptide presentation and T-cell activation. The TCR ...
Beyond recognition, peptides can also be used to modulate T-cell activityT-Cell Activating Peptide Libraries. Certain peptides can act as agonists or antagonists, influencing the strength and type of T-cell response. For example, super-agonist peptides have been developed that can prime a greater quantity of T cells than their natural sequences. Furthermore, peptides targeting specific molecular complexes, like the BTLA-HVEM complex, can modulate human T-cell activity, offering potential therapeutic avenues.作者：SK Saini·2019·被引用次数：119—Empty MHC reagents improve T cell detection. Recombinant MHC molecules displaying single peptides in their peptide-binding cleft are valuable ...
Peptide therapy has also been explored for its effects on T-cell responsesDifferent Types of T Cells and Their Functions - Akadeum Life Sciences. Studies have shown that peptide therapy can induce dose-dependent decreases in certain cytokine productions, suggesting shifts in T-cell phenotype or function. This highlights the potential of peptides not just for stimulating but also for regulating immune cells.Peptides for T cell selection in the thymus - PMC - NIH
Despite the critical role of t-cell peptides, challenges remain作者：SAE Galloway·2019·被引用次数：24—Overall, we conclude thatsuper agonist peptide MTSAIGILPV can prime a greater quantity of T-cellsthan is generated by the natural sequence EAAGIGILTV and that .... The vast diversity of TCRs and peptides means that understanding the precise rules governing their interaction is complex. TCR cross-reactivity, where a single TCR can recognize multiple different peptide-MHC complexes, adds another layer of complexity.T-cell receptor Research continues to unravel the nuances of peptide processing, presentation, and T-cell selection in the thymus, which shapes the mature T-cell repertoire.
The development of new technologies, such as engineered T-cell receptors (TCRs) with de novo peptide specificity and improved MHC reagents for T-cell detection, is advancing our ability to harness t-cell peptide interactions. As our understanding deepens, peptides will undoubtedly play an even more significant role in diagnostic tools, therapeutic strategies, and the fundamental study of the immune system.The T cell encounters a dendritic cell (DC) bearing its cognate peptidein an MHC molecule, and binds the peptide-MHC though CD3 and CD4 or 8. Subsequently ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.